|Previous Section||Index||Home Page|
In addition to the figures for those diagnosed with chlamydia in GUM clinics the total number of people who have been diagnosed with chlamydia within the National Chlamydia Screening Programme (NCSP) since 2003-04 when the programme was launched, is given in the following table:
|Diagnoses of Chlamydia in the NCSP|
National Chlamydia Screening Programme
John Smith: To ask the Secretary of State for Health what discussion the Chief Medical Officer (CMO) and his Department's Implementation Working Group have had with the National Institute for Health and Clinical Excellence (NICE) on the differences between the CMO's recommendations for the prevention of venous thromboembolism (VTE) in hospitalised patients and the NICE guidelines on reducing the risk of VTE in patients undergoing surgery; and if he will make a statement. 
Dawn Primarolo: The Chief Medical Officer and Dr. Anita Thomas OBE, the chair of the Implementation Working Group, have had discussions with the National Institute for Health and Clinical Excellence about improving the prevention and management of venous thromboembolism (VTE). The focus of these discussions has been on how all parties can work closely together to ensure that the risk of VTE can be minimised, for example by assessing what needs to be done to make a risk assessment for every hospitalised patient a reality.